Candel Therapeutics, Inc. (CADL) to Present Positive Phase 3 Prostate Cancer Data at ASCO 2025
Candel Therapeutics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,437,189 | $13,770,118 | -19% | 0.15% |
2. | Portolan Capital Management George Mccabe | 881,184 | $4,978,690 | +17% | 0.38% |
3. | 270,500 | $1,528,325 | -5% | 0% | |
4. | Marshall Wace LLP Paul Marshall And Ian Wace | 234,597 | $1,325,473 | 0% | |
5. | Millennium Management Israel Englander | 208,609 | $1,178,641 | +560% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$6.00 | 750,000 | 1,303,752 | 2024-12-16 | Filing | ||
$6.00 | 500,000 | 1,142,406 | 2024-12-16 | Filing | ||
$1.92 | 23,950 | Director | 152,000 | 2022-12-09 | Filing | |
$1.68 | 3,050 | Director | 128,050 | 2022-12-08 | Filing | |
$1.61 | 1,238 | Officer | 2,738 | 2022-12-08 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$8.76 | 45,316 | 52,493 | 2025-03-18 | Filing | ||
$8.76 | 32,146 | 96,527 | 2025-03-18 | Filing | ||
$9.00 | 400 | 225,740 | 2025-03-19 | Filing | ||
$8.77 | 25,772 | 226,140 | 2025-03-18 | Filing | ||
$8.82 | 31,278 | 85,512 | 2025-03-17 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 7,085,316 | $40,032,035 | 0% | |
2. | 2,152,252 | $12,160,224 | 8.11% | |
3. | 1,763,770 | $9,965,301 | 0% | |
4. | 1,736,104 | $9,808,988 | 0% | |
5. | 693,153 | $3,916,315 | 2% |